| Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease KM Pennington, A Vu, D Challener, CG Rivera, FNU Shweta, JD Zeuli, ... Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 24, 100244, 2021 | 81 | 2021 |
| Multicentre study of posaconazole delayed-release tablet serum level and association with hepatotoxicity and QTc prolongation NN Pettit, MH Miceli, CG Rivera, PP Narayanan, AJ Perissinotti, M Hsu, ... Journal of Antimicrobial Chemotherapy 72 (8), 2355-2358, 2017 | 30 | 2017 |
| Safety and tolerability of fluoroquinolones in patients with staphylococcal periprosthetic joint infections NJ Vollmer, CG Rivera, RW Stevens, CP Oravec, KC Mara, GA Suh, ... Clinical Infectious Diseases 73 (5), 850-856, 2021 | 29 | 2021 |
| Hepatotoxicity of contemporary antiretroviral drugs: a review and evaluation of published clinical data AO Otto, CG Rivera, JD Zeuli, Z Temesgen Cells 10 (5), 1263, 2021 | 24 | 2021 |
| The many faces of itraconazole cardiac toxicity HR Teaford, OMA Saleh, HR Villarraga, MJ Enzler, CG Rivera Mayo Clinic Proceedings: Innovations, Quality & Outcomes 4 (5), 588-594, 2020 | 23 | 2020 |
| Recent updates in antimicrobial stewardship in outpatient parenteral antimicrobial therapy MV Mahoney, LM Childs-Kean, P Khan, CG Rivera, RW Stevens, ... Current Infectious Disease Reports 23, 1-8, 2021 | 22 | 2021 |
| Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis MJ Karau, SM Schmidt-Malan, M Albano, JN Mandrekar, CG Rivera, ... The Journal of Infectious Diseases 222 (9), 1498-1504, 2020 | 20 | 2020 |
| Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program’s prospective review RW Stevens, L Estes, C Rivera Infection Control & Hospital Epidemiology 41 (9), 1108-1110, 2020 | 18 | 2020 |
| Impact of cefepime susceptible-dose-dependent MIC for Enterobacteriaceae on reporting and prescribing CG Rivera, PP Narayanan, R Patel, LL Estes Antimicrobial Agents and Chemotherapy 60 (6), 3854-3855, 2016 | 14 | 2016 |
| Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United States CG Rivera, KC Mara, MV Mahoney, KL Ryan Antimicrobial Stewardship & Healthcare Epidemiology 2 (1), e69, 2022 | 13 | 2022 |
| Standardizing febrile neutropenia management: antimicrobial stewardship in the hematologic malignancy population JC O’Horo, JR Marcelin, OM Abu Saleh, AK Barwise, PM Odean, ... Journal of oncology practice 15 (9), e843-e848, 2019 | 11 | 2019 |
| Contemporary pharmacotherapies for nontuberculosis mycobacterial infections: a narrative review TM Johnson, TF Byrd, WK Drummond, LM Childs-Kean, MV Mahoney, ... Infectious Diseases and Therapy 12 (2), 343-365, 2023 | 9 | 2023 |
| Role of infectious diseases pharmacists in outpatient intravenous and complex oral antimicrobial therapy: Society of Infectious Diseases Pharmacists insights CG Rivera, M Mehta, KL Ryan, RW Stevens, KJ Tucker, MV Mahoney Journal of the American College of Clinical Pharmacy 4 (9), 1161-1169, 2021 | 9 | 2021 |
| Clinical pharmacists’ interventions and therapeutic drug monitoring in patients with mycobacterial infections AM Woods, KC Mara, CG Rivera Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 30, 100346, 2023 | 8 | 2023 |
| Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo NW Cummins, J Baker, R Chakraborty, PG Dean, E Garcia-Rivera, ... EClinicalMedicine 42, 2021 | 8 | 2021 |
| Hepatotoxicity of contemporary antiretroviral drugs CG Rivera, AO Otto, JD Zeuli, Z Temesgen Current Opinion in HIV and AIDS 16 (6), 279-285, 2021 | 8 | 2021 |
| Out of sight but not out of mind: caring for patients receiving OPAT during the SARS-CoV-2 pandemic CG Rivera, MV Mahoney, RW Stevens, O Abu Saleh Open Forum Infectious Diseases 7 (8), ofaa309, 2020 | 8 | 2020 |
| Time to treat: applying lessons learned from other viral syndromes to SARS-CoV-2 RW Stevens, CG Rivera, OA Saleh Mayo Clinic Proceedings: Innovations, Quality & Outcomes 4 (6), 759-763, 2020 | 7 | 2020 |
| Evaluating antimicrobial duration for Gram‐negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation N Ranganath, ZA Yetmar, AR McCandless, CG Rivera, BD Lahr, ... Transplant Infectious Disease 25 (5), e14085, 2023 | 5 | 2023 |
| Heartbreaking decisions: The dogma and uncertainties of antimicrobial therapy in infective endocarditis JL Adema, A Ahiskali, M Fida, K Mediwala Hornback, RW Stevens, ... Pathogens 12 (5), 703, 2023 | 5 | 2023 |
Omar Abu salehInfectious diseases, Mayo Clinic在 mayo.edu 的电子邮件经过验证
